GIOSTAR Co-Founders Dr. Anand Srivastava and Deven Patel recently spoke with Dr. Amy Killen about the company’s ongoing research efforts related to coronavirus (COVID-19). Dr. Anand explains in great detail the mechanisms underlying the disease, including cytokine storms and the potential immunomodulatory benefits of mesenchymal stem cells (MSCs). Additionally, he provides an overview of ongoing investigations in this arena, including a recent study by an international research team published in Aging and Disease
Coronavirus (COVID-19) is truly an unprecedented pandemic that has wrought incredible damage to populations worldwide. Healthcare providers are scrambling to contain the impact of this deadly disease, exploring all potential remedies while scientists work to develop an effective vaccine.
Earlier this year, GIOSTAR received approval to treat patients suffering from COVID-19. Patients will be treated using stem cells, under the US Food and Drug Administration (FDA) expanded access (or “compassionate use”) program. GIOSTAR is currently in the process of evaluating stem cell therapy for a small number of patients, and is seeking approval for a broader clinical trial. This practice aligns with the company’s emphasis on working with regulatory agencies and adhering to the policies and procedures of each country in which they operate.
About Dr. Amy Killen
Dr. Amy Killen is a board-certified physician specializing in aesthetics, anti-aging, and regenerative medicine. After 10 years of experience in emergency medicine and direct patient care, she transitioned to preventative and regenerative medicine more than five years ago to better help her patients realize optimal health and longevity. Her areas of focus include aesthetics, platelet rich plasma (PRP) and stem cells, hair restoration, bio-identical hormones, nutrition, and fitness.
She serves as Medical Director of BioRestoration Medical, a busy clinic with a comprehensive, integrative approach to health located in Draper, Utah. Dr. Killen also works at Docere Medical in Park City, Utah with Dr. Harry Adelson, providing cutting edge regenerative medical treatments for a host of different conditions.
How Can We Help You?
GIOSTAR has been a pioneer in stem cell therapy and research since its founding 12 years ago. Leveraging more than two decades of groundbreaking research by Co-Founder and Chairman Dr. Anand Srivastava, GIOSTAR has helped thousands of patients around the globe suffering from various degenerative diseases and orthopedic conditions.